Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Liabilities from Discontinued Operations (2016)

Historic Liabilities from Discontinued Operations for Niagen Bioscience (NAGE) over the last 1 years, with Q4 2016 value amounting to $184766.0.

  • Niagen Bioscience's Liabilities from Discontinued Operations changed N/A to $184766.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $184766.0, marking a year-over-year change of. This contributed to the annual value of $184766.0 for FY2016, which is N/A changed from last year.
  • Per Niagen Bioscience's latest filing, its Liabilities from Discontinued Operations stood at $184766.0 for Q4 2016.
  • Over the past 5 years, Niagen Bioscience's Liabilities from Discontinued Operations peaked at $184766.0 during Q4 2016, and registered a low of $184766.0 during Q4 2016.